183 related articles for article (PubMed ID: 9700940)
21. Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis.
Curtis LD
Adv Exp Med Biol; 1996; 416():361-3. PubMed ID: 9131174
[No Abstract] [Full Text] [Related]
22. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
Drugs Exp Clin Res; 1997; 23(5-6):191-9. PubMed ID: 9515229
[TBL] [Abstract][Full Text] [Related]
23. Effect of endotoxin and platelet-activating factor on rat vascular permeability: role of vasoactive mediators.
Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
J Lipid Mediat Cell Signal; 1997 Sep; 17(1):31-45. PubMed ID: 9302653
[TBL] [Abstract][Full Text] [Related]
24. Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats.
Rivera JA; Werner J; Warshaw AL; Lewandrowski KB; Rattner DW; Fernández del Castillo C
Int J Pancreatol; 1998 Apr; 23(2):101-6. PubMed ID: 9629507
[TBL] [Abstract][Full Text] [Related]
25. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis.
Kingsnorth AN; Galloway SW; Formela LJ
Br J Surg; 1995 Oct; 82(10):1414-20. PubMed ID: 7489182
[TBL] [Abstract][Full Text] [Related]
26. Intestinal microcirculation and gut permeability in acute pancreatitis: early changes and therapeutic implications.
Hotz HG; Foitzik T; Rohweder J; Schulzke JD; Fromm M; Runkel NS; Buhr HJ
J Gastrointest Surg; 1998; 2(6):518-25. PubMed ID: 10458730
[TBL] [Abstract][Full Text] [Related]
27. Lexipafant inhibits platelet activating factor enhanced neutrophil functions.
Schwartz JD; Shamamian P; Grossi EA; Schwartz DS; Marcus SG; Steiner F; Jacobs CE; Tayyarah M; Eng K; Colvin SB; Galloway AC
J Surg Res; 1997 May; 69(2):240-8. PubMed ID: 9224389
[TBL] [Abstract][Full Text] [Related]
28. Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis.
Johnson CD
Dig Surg; 1999; 16(2):93-101. PubMed ID: 10207233
[TBL] [Abstract][Full Text] [Related]
29. Role of endogenous platelet-activating factor in caerulein-induced acute pancreatitis in rats: protective effects of a PAF-antagonist.
Fujimura K; Kubota Y; Ogura M; Yamaguchi T; Binnaka T; Tani K; Kitagawa S; Mizuno T; Inoue K
J Gastroenterol Hepatol; 1992; 7(2):199-202. PubMed ID: 1571504
[TBL] [Abstract][Full Text] [Related]
30. Mast cells contribute to early pancreatitis-induced systemic endothelial barrier dysfunction.
Dib M; Zhao X; Wang X; Andersson R
Pancreatology; 2002; 2(4):396-401. PubMed ID: 12138228
[TBL] [Abstract][Full Text] [Related]
31. Gut barrier dysfunction in experimental acute pancreatitis.
Andersson R; Wang XD
Ann Acad Med Singap; 1999 Jan; 28(1):141-6. PubMed ID: 10374040
[TBL] [Abstract][Full Text] [Related]
32. Alterations in intestinal motility and microflora in experimental acute pancreatitis.
Leveau P; Wang X; Soltesz V; Ihse I; Andersson R
Int J Pancreatol; 1996 Oct; 20(2):119-25. PubMed ID: 8968867
[TBL] [Abstract][Full Text] [Related]
33. Antioxidant and calcium channel blockers counteract endothelial barrier injury induced by acute pancreatitis in rats.
Wang XD; Deng XM; Haraldsen P; Andersson R; Ihse I
Scand J Gastroenterol; 1995 Nov; 30(11):1129-36. PubMed ID: 8578176
[TBL] [Abstract][Full Text] [Related]
34. Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials.
Abu-Zidan FM; Windsor JA
Eur J Surg; 2002; 168(4):215-9. PubMed ID: 12440758
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of vascular endothelial growth factor on intestinal epithelial apoptosis and bacterial translocation in experimental severe acute pancreatitis.
Nakajima T; Ueda T; Takeyama Y; Yasuda T; Shinzeki M; Sawa H; Kuroda Y
Pancreas; 2007 May; 34(4):410-6. PubMed ID: 17446839
[TBL] [Abstract][Full Text] [Related]
36. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
Mann O; Tiefenbacher WJ; Kaifi J; Schneider C; Kluth D; Bloechle C; Yekebas E; Izbicki JR; Strate T
Pancreas; 2009 Jan; 38(1):58-64. PubMed ID: 18695628
[TBL] [Abstract][Full Text] [Related]
37. Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates.
Foitzik T; Eibl G; Hotz HG; Faulhaber J; Kirchengast M; Buhr HJ
Surgery; 2000 Sep; 128(3):399-407. PubMed ID: 10965310
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.
Schifitto G; Sacktor N; Marder K; McDermott MP; McArthur JC; Kieburtz K; Small S; Epstein LG
Neurology; 1999 Jul; 53(2):391-6. PubMed ID: 10430432
[TBL] [Abstract][Full Text] [Related]
39. Reversal of the effect of albumin on gut barrier function in burn by the inhibition of inducible isoform of nitric oxide synthase.
Chen LW; Wang JS; Hwang B; Chen JS; Hsu CM
Arch Surg; 2003 Nov; 138(11):1219-25. PubMed ID: 14609870
[TBL] [Abstract][Full Text] [Related]
40. The influence of circulatory and gut luminal challenges on bidirectional intestinal barrier permeability in rats.
Sun ZW; Wang XD; Deng XM; Wallén R; Gefors L; Hallberg E; Andersson R
Scand J Gastroenterol; 1997 Oct; 32(10):995-1004. PubMed ID: 9361172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
